Hepatitis B surface antigen and hepatitis B core-related antigen levels can predict long-term response to sequential nucleos(t)ide analogue and interferon-α therapy in patients with chronic hepatitis B virus infection, research indicates.
from The Medical News http://ift.tt/1BClnek
from The Medical News http://ift.tt/1BClnek
No comments:
Post a Comment